The quest to extend human healthspan and delay the ravages of time just received a financial boost. Functional Longevity Labs, a Maryland-based pharmaceutical company, has closed a $130K seed round.
The company is focused on developing therapies that leverage a deep scientific understanding of the aging process. Its work aims to maximize healthspan and push back the onset of age-associated disease, ultimately seeking to prolong the period of life spent in good health.













